Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update-Reference-Cited by-同舟云学术

Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update

Published:2021-06 Issue:6 Volume:96 Page:1546-1577
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Muchtar Eli^ORCID,Dispenzieri Angela,Gertz Morie A.^ORCID,Kumar Shaji K.,Buadi Francis K.,Leung Nelson,Lacy Martha Q.,Dingli David^ORCID,Ailawadhi Sikander,Bergsagel P. Leif,Fonseca Rafael^ORCID,Hayman Suzanne R.,Kapoor Prashant,Grogan Martha,Abou Ezzeddine Omar F.,Rosenthal Julie L.,Mauermann Michelle^ORCID,Siddiqui Mustaqueem,Gonsalves Wilson I.^ORCID,Kourelis Taxiarchis V.^ORCID,Larsen Jeremy T.,Reeder Craig B.,Warsame Rahma^ORCID,Go Ronald S.^ORCID,Murray David L.,McPhail Ellen D.^ORCID,Dasari Surendra^ORCID,Jevremovic Dragan,Kyle Robert A.^ORCID,Lin Yi^ORCID,Lust John A.,Russell Stephen J.,Hwa Yi Lisa,Fonder Amie L.,Hobbs Miriam A.,Rajkumar S. Vincent^ORCID,Roy Vivek^ORCID,Sher Taimur^ORCID

Funder

Mayo Clinic Arizona

Publisher

Elsevier BV

Subject

General Medicine

Reference198 articles.

1. Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples;Dasari;Mayo Clin Proc,2020

2. Incidence of AL amyloidosis in Olmsted County, Minnesota, 1990 through 2015;Kyle;Mayo Clin Proc,2019

3. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee;Benson;Amyloid,2018

4. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue;Brambilla;Blood,2012

5. Classification of amyloidosis by laser microdissection and mass spectrometry–based proteomic analysis in clinical biopsy specimens;Vrana;Blood,2009

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with a cardiac complete response in AL amyloidosis have survival rates similar to those of a matched general population;Blood;2024-08-15

2. Liquid chromatography-tandem mass spectrometry in clinical laboratory protein measurement;Clinica Chimica Acta;2024-08

3. Role of Autologous Stem Cell Transplantation in Systemic Light Chain Amyloidosis;Clinical Lymphoma Myeloma and Leukemia;2024-07

4. Timing and co-occurrence of symptoms prior to a diagnosis of light chain (AL) amyloidosis;Blood Cancer Journal;2024-05-26

5. The mechanism of action, pharmacological characteristics, and clinical utility of the amyloid depleter birtamimab for the potential treatment of AL amyloidosis;Leukemia & Lymphoma;2024-04-11